Ionis Pharmaceuticals (IONS) Long-Term Investments (2010 - 2012)

Ionis Pharmaceuticals' Long-Term Investments history runs 3 years deep, the most recent figure standing at -$5.6 million for Q3 2012.

• In Q3 2012, Long-Term Investments fell 76.88% year-over-year to -$5.6 million; the TTM figure through Sep 2012 stood at -$5.6 million (down 76.88% YoY), while the FY2011 annual figure was -$4.4 million, down 408.51% from the prior year.
• Long-Term Investments for Q3 2012 stood at -$5.6 million, roughly flat from -$5.6 million in the prior quarter.
• The five-year high for Long-Term Investments was -$870000.0 in Q4 2010, with the low at -$5.6 million in Q2 2012.
• The 3-year median for Long-Term Investments is -$4.2 million (2010), against an average of -$3.9 million.
• Peak annual rise in Long-Term Investments reached 37.1% in 2011, while the deepest fall reached 408.51% in 2011.
• Ionis Pharmaceuticals' Long-Term Investments stood at -$870000.0 in 2010, then sank by 408.51% to -$4.4 million in 2011, then declined by 25.75% to -$5.6 million in 2012.
• Business Quant data shows IONS's Long-Term Investments at -$5.6 million in Q3 2012, -$5.6 million in Q2 2012, and -$5.4 million in Q1 2012.